Latest News for: sandoz

Edit

Batch recall – Esomeprazol MUT Sandoz magensaftresistente Tabletten (Swissmedic - Swiss Agency for Therapeutic Products)

Public Technologies 23 Dec 2025
) 23.12.2025 Präparat Esomeprazol MUT Sandoz, magensaftresistente Tabletten Zulassungsnummer 65960 Wirkstoff [...] ... Disclaimer ... (noodl.
Edit

aide-memoire-2025-q4 (Sandoz Group AG)

Public Technologies 16 Dec 2025
Ahead of the publication of its full-year results and fourth-quarter sales update on 25 February 2026, Sandoz would like to highlight the following important considerations and prior disclosures ... Sandoz launches Tyruko in US ... craig.marks@sandoz.com.
Edit

Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz

Black Hills Pioneer 12 Dec 2025
All closing requirements satisfied following announcement ...
Edit

Blaze Marks and Written Description: Patent Drafting Lessons from Duke v. Sandoz (Morrison & Foerster LLP)

Public Technologies 10 Dec 2025
) On November 18, 2025, the U.S ... Sandoz Inc., holding claim 30 of U.S. Patent No. 9,579,270 ("the '270 patent") invalid for lack of written description.
Edit

Evotec closes sale of Just – Evotec Biologics’ Toulouse site to Sandoz (Form 6-K) (Evotec SE)

Public Technologies 08 Dec 2025
Evotec closes sale of Just - Evotec Biologics' Toulouse site to Sandoz • All closing requirements satisfied following announcement of a non-binding term-sheet agreement in July and signing of contract in November.
Edit

Sandoz Group AG (Baillie Gifford European Growth Trust plc)

Public Technologies 27 Nov 2025
). Valuation as at 31 August 2025. Asset Name. ISIN Number. Holding. Market Value. (GBP). % Total Assets. Listed Equities. Adyen NV. NL0012969182. 12,329. 15,319,252. 3.8. Allegro.eu. LU2237380790. 1,819,860. 13,498,062. 3.3. Amplifon. IT0004056880 ... Sandoz Group AG Shs.
Edit

Renal Anemia Market Research Report 2025-2035, Competitive Analysis of Amgen, Sandoz, Pfizer, GlaxoSmithKline, Akebia Therapeutics, ...

Nasdaq Globe Newswire 18 Nov 2025
The global renal anemia market is experiencing significant growth, driven by advancements in therapeutic options, increased diagnostic accuracy, and enhanced healthcare investments in the U.S., Europe, and emerging markets ... .
Edit

VMA, Sandoz Vietnam partner to raise awareness of antimicrobial resistance

Vietnam News 18 Nov 2025
“Today’s signing is another important step in our shared mission to combat antimicrobial resistance, a silent but growing threat to public health in Vietnam and around the world,” said Charaf Eddine Kadri, General Director of Sandoz Vietnam.
Edit

Sandoz launches TYRUKO® (natalizumab-sztn) in US, as first and only multiple sclerosis biosimilar (Sandoz Group AG)

Public Technologies 17 Nov 2025
17/11/2025 Sandoz launches TYRUKO® (natalizumab-sztn) in US, as first and only multiple sclerosis biosimilar ... Keren Haruvi, President Sandoz North America, said ... TYRUKO® is expected to be a key contributor to the Sandoz growth strategy ... ABOUT SANDOZ.
Edit

Pioneering sustainable science: Sandoz labs achieve My Green Lab Certification (Sandoz Group AG)

Public Technologies 13 Nov 2025
Sandoz labs achieve My Green Lab Certification. At Sandoz, our Purpose - pioneering access for patients - means even more than delivering high-quality generics and biosimilars ... Sustainability at Sandoz.
Edit

Pulmonary Arterial Hypertension Market Research Report 2025, Competitive Analysis of Gilead Sciences, Viatris, Sandoz, J&J, ...

Nasdaq Globe Newswire 11 Nov 2025
The shift towards personalized medicine and digital health tools also offers avenues for optimizing treatment efficacy and patient management ... .
Edit

New report highlights growing threat to sustainable European supply of critical antibiotics, calls for urgent policy reform (Sandoz Group AG)

Public Technologies 10 Nov 2025
) ... Penicilllin Valley ... Richard Saynor, CEO of Sandoz, who sponsored the report, says ... Attachments Original document Permalink ... Sandoz Group AG published this content on November 10, 2025, and is solely responsible for the information contained herein.
Edit

New report highlights growing threat to sustainable European supply of system-critical antibiotics, calls for urgent policy reform (Sandoz Group AG)

Public Technologies 10 Nov 2025
) ... Richard Saynor, CEO of Sandoz, who sponsored the report, says ... The full report (in two versions) is available here ... Sandoz Group AG published this content on November 10, 2025, and is solely responsible for the information contained herein ... (noodl.
Edit

In a landmark industry transaction, Evotec signs agreement with Sandoz, resulting in payments potentially over US$ 650 m plus royalties on portfolio of up to 10 biosimilar molecules (Form 6-K) (Evotec SE)

Public Technologies 05 Nov 2025
EVO), a life science company that is pioneering the future of drug discovery and development, today announced the successful signing of the sale of the Just - Evotec Biologics Toulouse site to Sandoz AG (SIX.
Edit

In A Landmark Industry Transaction, Evotec Signs Agreement With Sandoz, Resulting In Payments Potentially Over ...

ACCESSWIRE 05 Nov 2025
Under the landmark transaction, Sandoz will acquire 100% of Just - Evotec Biologics EU plus an indefinite technology license to Evotec's continuous manufacturing platform technology for a payment of approximately US$ 350 m in cash.

Article Search

tools
×
×
×
×